The website uses cookies that do not contain personal data and serve for the sole purpose of improving the user experience. Your presence on the website implies that you agree to the use of these cookies. For more details about personal data protection, please read the following link.
Issuer
Replek AD Skopje
Issuer's basic data
Address
Ul.Kozle 188
City
Skopje
State
Makedonija
Mail
info@replek.mk
Site
http://www.replek.mk/
Contact person +
Ofelija Petkovikj
Phone
+389 2 3081 343
Fax
/
Prospectus
Download Prospectus
Year 2024 2023 2022
Total Revenue from operation Activities 1,948,035 1,587,371 1,251,666
Operating profit 276,949 307,565 104,776
Net profit 224,195 280,628 81,937
Equity 2,367,887 2,298,036 1,533,835
Total liabilities 940,175 703,197 729,264
Total assets 3,308,062 3,001,233 2,263,099
Market capitalization 4,302,287 2,410,560 2,269,296
* data in 000 MKD
Methodology
Year 2024 2023 2022
Return on sales 14.22% 19.38% 8.37%
Net earnings per share (EPS) 864.95 1,082.67 316.11
Return on assets 6.78% 9.35% 3.62%
Return on equity 9.47% 12.21% 5.34%
Price to earnings 19.19 8.59 27.70
Book value per share 9,135.37 8,865.88 5,917.57
Price to Book Value 1.82 1.05 1.48
Dividend Per Share 400.00 300.00 200.00
Dividend yield 2.41% 3.23% 2.28%
*Due to the corporate stock split event, the Net Earnings Per Share (EPS), Book Value Per Share and Dividend Per Share figures for previous years have been adjusted for the number of shares
Replek is a company whose main activity is the production of pharmaceutical products, cosmetic products and cannabis products. The production range of the company has high quality products, for the production of which the company has an EU GMP quality certificate. Within the framework of the market strategy, the company also focuses on trade, ie. import of drugs, nutritional supplements and medical devices, registration and marketing of drugs, logistics as well as development and support of sales strategies for different markets and partners. Currently, the company is represented in 20 countries around the world. By providing high quality services and products, the company has a significant place in the domestic pharmaceutical market. With the constant development of innovative products and services, the company promotes the well-being of all participants – users, employees and of course shareholders.

Managing Board
Dushan Pecovski - President and General manager
Gelevski Pance
Kosta Koteski
Marjan Velkovski
Supervisory Board 
Antonio Georgievski - President
Petar Andreevski
Tomislav Krstevski - member
Naum Janakiev 
Jana Juzina - independent member

  1. Share buy-backs and non-trade transfers of listed companies' shares

    We inform you about executed share buy-backs and non-trade transfers of listed companies' shares

  2. Share buy-backs and non-trade transfers of listed companies' shares

    We inform you about executed share buy-backs and non-trade transfers of listed companies' shares

  3. Block trade
    Block trade with shares of Replek AD Skopje

  4. Non-trade transfers of listed companies' share
    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed

  5. Non-trade transfers of listed companies' share
    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed

  6. Non-trade transfers of listed companies' share
    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed

  7. Non-trade transfers of listed companies' share
    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed

  8. Block trade
    Block trade with shares of Replek AD Skopje

  9. Non-trade transfers of listed companies' share
    According to the data from the Central Securities Depositary we inform that the following non-trade transfers of listed companies' shares were executed

  10. Block trade
    Block trade with shares of Replek AD Skopje
Symbols
Price movement
Volume
Symbol data
Market segment:
Exchange Listing - Ordinary shares
ISIN:
MKREPL101013
Total shares
259,200
Last trade: 4/17/2025
Max Price:
15,998.00
Min Price:
15,998.00
Avg Price:
15,998.00
Volume:
2
Value:
31,996
Trades:
1
Last 52 weeks
Max Price:
18,998.00
Min Price:
10,900.00
Volume:
15,140
Value:
292,701,421
Trades:
1,116

* the average price is from the last trading day

**data doesn't inculde block trades

*** the ordinary shares and the priority shares own by the Pension and Disability Insurance Fund of the Republic of Macedonia – PDIF (if they are issued) are summed up. The priority shares own by the PDIF are converted in ordinary shares at the moment of sale.

****12.07.2024 - REPL carried out a stock split in ratio 1:10 and according that change was made an adjustment of the average price of the share

Historical Data